Komipharm International Co., Ltd. (KOSDAQ:041960)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Veterinary Medicine Manufacturing and Sales	58.78B	42.65B	39.80B	35.85B	37.16B
Veterinary Medicine Manufacturing and Sales Growth	37.83%	7.15%	11.03%	-3.53%	4.71%
Total	58.78B	42.65B	39.80B	35.85B	37.16B
Total Growth	37.83%	7.15%	11.03%	-3.53%	4.71%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
South Korea	38.44B	27.25B	24.43B	23.67B	21.92B
South Korea Growth	41.06%	11.56%	3.21%	7.96%	-2.12%
Overseas	20.33B	15.39B	15.37B	12.18B	15.24B
Overseas Growth	32.10%	0.15%	26.22%	-20.08%	16.38%
Total	58.78B	42.65B	39.80B	35.85B	37.16B
Total Growth	37.83%	7.15%	11.03%	-3.53%	4.71%

Source: S&P Global Market Intelligence.